Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
30 participants
INTERVENTIONAL
2008-11-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stem Cells Therapy in Advanced Heart Failure
NCT02871466
Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
NCT00743639
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
NCT01557543
To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction
NCT00526253
Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
NCT01957826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacing and Stem Cells Implantations.
Implantation of Cardiac Ressyncrhonization combined with the implantation of Stem Cells Hematopoietics.
Pacing and Stem Cells Implantation
Pacing and Stem Cells Implantation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Heart Failure
* Optimized Therapeutics
* Ventricular Desynchrony
* Functional Class III or IV
* Ejection Fraction(Echo/ Sympson) \< 35%
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Instituto de Molestias Cardiovasculares
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IMC - Instituto de Moléstias Cardiovasculares
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oswaldo Tadeu Greco, PhD
Role: PRINCIPAL_INVESTIGATOR
IMC - Institute of Hearth Diseases
Oswaldo Tadeu Greco, PhD
Role: PRINCIPAL_INVESTIGATOR
IMC- Institute of Hearth Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imc - Instituto de Moléstias Cardiovasculares
São José do Rio Preto, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Jacob JL, Salis FV, Ruiz MA, Greco OT. Labeled stem cells transplantation to the myocardium of a patient with Chagas' disease. Arq Bras Cardiol. 2007 Aug;89(2):e10-1. doi: 10.1590/s0066-782x2007001400014. English, Portuguese.
Related Links
Access external resources that provide additional context or updates about the study.
Departamento de Estimulação Cardiaca e Arritmia.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HFRCTC1
Identifier Type: -
Identifier Source: secondary_id
HFRCTC1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.